Immunocellular(美国)

Immunocellular

美国ImmunoCellularTherapeuticswww.imuc.comIMUC是一家总部位于洛杉矶的临床阶段公司，致力于开发免疫疗法来治疗脑癌和其它癌症。该公司的先导候选产品ICT-107最近进入II期试验，ICT-107是一种基于树突状细胞的疫苗，该疫苗以多个肿瘤相关抗原为靶向，用于治疗新诊断出的胶质母细胞瘤。Ourmissionistoimprovecancertreatmentan ddiagnosisthroughthediscoveryanddevelopmentofnewimmune-basedproducts.Designedtoharnessbotharmsofthenativeimmunesystem,ourpipelineincludesbothactiveimmunotherapiesandpatentedmonoclonalantibodies(mABs).Ouractiveimmunotherapiestargetnotonlyregulartumorcells,butalsothecancerstemcellsbelievedtocausecancergrowthandrecurrence.Ourmostadvancedclinicalprogramsareinglioblastomamultiforme(GBM),butourtechnologieshavepotentialapplicationsinmanycancerswithhighunmetmedicalneed,includingpancreatic,ovarian,colon,small-celllung,andmultiplemyeloma.OurleadproductcandidateisICT-107,apersonalized,dendriticcell-basedvaccineforthetreatmentofGBM.Weintendtoinitiate